These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 13797315)

  • 1. [The treatment of acute cerebrovascular disorders by the nicotinic acid ester of 7-(2-hydroxyethyl)-theophylline (hesotin)].
    BARTOUSEK V; CERNY J; DUBANSKY B
    Ther Umsch; 1960 May; 17():182-5. PubMed ID: 13797315
    [No Abstract]   [Full Text] [Related]  

  • 2. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dimethylxanthine nicotinate].
    LENNARTZ H
    Arzneimittelforschung; 1962 Jul; 12():675-9. PubMed ID: 14463992
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on the changes in the cerebral blood volume under the influence of 3-(methylhydroxyethylamino)-2-hydroxypropyl-theophylline nicotinate with the aid of cranial rheography].
    SCHREIBER H
    Med Klin; 1960 Mar; 55():509-11. PubMed ID: 14443546
    [No Abstract]   [Full Text] [Related]  

  • 4. [2-hydroxy-3-(N-2-hydroxyethyl-N-methylamino)-propyl]-1,3-dim-exthylxanthinenicotinate on cerebrospinal fluid pressure and cerebral circulation].
    HEMMER R; DIEZEMANN E
    Arzneimittelforschung; 1962 Jul; 12():672-5. PubMed ID: 13906366
    [No Abstract]   [Full Text] [Related]  

  • 5. [Research on the action of Complamin on systemic circulation and the peripheral skin circulation].
    HEIM E; STORCK H
    Ther Umsch; 1961 Nov; 18():447-51. PubMed ID: 13906019
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
    FRUHMANN H
    Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155
    [No Abstract]   [Full Text] [Related]  

  • 7. [Analysis of the pharmacodynamic properties of the nicotinic ester of 7-(2-hydroxyethyl)-theophylline. II. Cardiocirculatory effects in subjects with cerebral and peripheral angiopathies].
    De Gregorio G; Scaffidi L; Arcoraci A
    Cardiol Prat; 1971 Oct; 22(5):329-36. PubMed ID: 5136470
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of niacinamide on cerebral circulation.
    HUANG TF; CHAO CC
    Proc Soc Exp Biol Med; 1960 Dec; 105():551-3. PubMed ID: 13716402
    [No Abstract]   [Full Text] [Related]  

  • 9. [COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
    DEGREGORIO G; BUDA A; FIDECARO A
    Riforma Med; 1964 Aug; 78():937-41. PubMed ID: 14222308
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical experiences with the nicotinic acid ester of hydroxyethltheophylline (hesotin) in the treatment of cerebral & peripheral circulation disorders].
    BRUNNER F
    Wien Med Wochenschr; 1959 Jun; 109(23):484-5. PubMed ID: 13669483
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON COMPLAMIN].
    JENSEN BS
    Ugeskr Laeger; 1963 Aug; 125():1167-70. PubMed ID: 14045855
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the effects of drugs on the cerebral vessels].
    GLONING K; KLAUSBERGER EM
    Wien Klin Wochenschr; 1959 Nov; 71():880-3. PubMed ID: 13828490
    [No Abstract]   [Full Text] [Related]  

  • 13. [ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
    LOOS M
    Med Welt; 1964 Aug; 32():1710-2. PubMed ID: 14291150
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical trial of the treatment of peripheral circulation disorders with Complamine].
    SPERLING M
    Munch Med Wochenschr; 1962 Jul; 104():1273-8. PubMed ID: 13915730
    [No Abstract]   [Full Text] [Related]  

  • 15. [he nicotinic acid of diethylaminoethyltheophylline].
    QUEVAUVILLER A; MORIN H
    Therapie; 1956; 11(4):725-9. PubMed ID: 13352304
    [No Abstract]   [Full Text] [Related]  

  • 16. [methylhydroxyethylamino]-2-hydroxypropyltheophylline nicotinate)].
    GOTTSTEIN U; BERNSMEIER A; STEINER K
    Klin Wochenschr; 1962 Aug; 40():772-8. PubMed ID: 13900788
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the treatment of dermatological disease pictures with Complamin].
    KLEINHANS H
    Med Klin; 1962 Feb; 57():239-40. PubMed ID: 14456820
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activation of fibrinolysis with Complamin].
    FISCHBACHER W
    Ther Umsch; 1961 Nov; 18():452-9. PubMed ID: 13893098
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the treatment of cerebral sclerosis with complamine].
    KESSENS L
    Med Welt; 1960 Nov; 47():2517-8. PubMed ID: 13752735
    [No Abstract]   [Full Text] [Related]  

  • 20. [CLINICO-ELECTROENCEPHALOGRAPHIC FINDINGS IN VASOACTIVE TREATMENT WITH COMPLAMIN].
    FLUEGEL KA; MENGI E; CORA R
    Med Klin; 1964 Nov; 59():1831-5. PubMed ID: 14330837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.